$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
瑞格非尼降低胃肠道间质瘤患者疾病进展风险
2025-10-19 11:44:20
Check Details
瑞格非尼获批治疗晚期胃肠道间质瘤患者
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗胃肠道间质瘤患者
2025-10-19 11:44:20
Check Details
舒尼替尼使胃肠道间质瘤患者受益
2025-10-19 11:44:20
Check Details
舒尼替尼降低胃肠间质瘤患者50%死亡风险
2025-10-19 11:44:20
Check Details
舒尼替尼治疗胃肠间质瘤的数据
2025-10-19 11:44:20
Check Details
瑞格非尼治疗胃肠道间质瘤
2025-10-19 11:44:20
Check Details
瑞戈非尼获批用于治疗胃肠道间质瘤
2025-10-19 11:44:20
Check Details
瑞格非尼治疗胃肠道间质瘤(GIST)患者
2025-10-19 11:44:20
Check Details
舒尼替尼治疗格列卫不耐受的胃肠道间质瘤
2025-10-19 11:44:20
Check Details
舒尼替尼剂量如何调整
2025-10-19 11:44:20
Check Details
瑞格非尼治疗舒尼替尼耐药胃肠道间质瘤患
2025-10-19 11:44:20
Check Details
1
2
...
718
719
720
721
722
723
724
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
2
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
3
Comprehensive Analysis of the Third-Generation EGFR-TKI
4
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
5
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
6
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
7
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
8
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
9
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
10
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
11
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
12
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook